Select languageSelect language
Institute of Physiology and Pathophysiology

Prof. Dr. rer. nat. Markus Hecker

Heidelberg University

Institute of Physiology and Pathophysiology

Division of Cardiovascular Physiologie

Im Neuenheimer Feld 326

69120 Heidelberg

Germany

phone:

+49 6221 54-4036/4035

fax:

+49 6221 54-4038

e-mail:

hecker@physiologie.uni-heidelberg.de

Curriculum Vitae

2014-2016

Managing Director of the Institute of Physiology and Pathophysiology, Heidelberg University, Germany

2012

Specialist of Physiology (German Physiological Society)

since 2006

Head of the Division of Cardiovascular Physiology, Institute of Physiology and Pathophysiology, Heidelberg University, Germany

2006-2011

Managing Director of the Institute of Physiology and Pathophysiology, Heidelberg University, Germany

since 2004

Full Professor (C4) and Director, Institute of Physiology and Pathophysiology, Heidelberg University, Germany

2001-2003

Managing partner, AVONTEC GmbH, Göttingen, Germany

1996-2004

Full Professor (C3) and Head, Department of Cardiovascular Physiology, Göttingen University, Germany

1993-1996

Assistant Professor in the Department of Cardiovascular Physiology, University of Frankfurt, Germany

1993

State doctorate (Dr. rer. nat., habil. in Physiology), Faculty of Medicine, University of Freiburg, Germany

1993

Specialist of Pharmacology (German Society of Experimental and Clinical Pharmacology and Toxicology)

1991-1993

Lecturer in the Department of Applied Physiology, University of Freiburg, Germany

1990-1991

Senior Scientist and Honorary Lecturer, William Harvey Research Institute, St. Bartholomew’s Hospital Medical College, London, UK

1989-1990

Postdoc, William Harvey Research Institute, St. Bartholomew’s Hospital Medical College, London, UK

1988-1989

Postdoc, Department of Physiology and Biophysics, Georgetown University, Washington, DC, USA

1988

Dr. rer. nat. (Ph. D. in Biochemical Pharmacology), University of Konstanz, Germany

1986-1989

Post-graduate in the Research Training Group Biochemical Pharmacology, University of Konstanz, Germany

1985

Diploma (M. Sc. in Biology), University of Konstanz, Germany

1980-1985

Study of Biology, University of Konstanz, Germany

Honors and Awards

2003

German Founders Award in the category "Concept" (together with G. Hasenfuss)

2000

Wulf Vater-Dihydropyridine Research Award, Wulf Vater-Foundation (together with M. Cattaruzza, R. Wachter and A.H. Wagner)

1994

Award of the Dr. Heinz und Helene Adam-Foundation for Research on Human Blood and Lymph Vessels

1993

Sandoz Award for therapy-related pharmacological research, German Societey for Experimental and Clinical Pharmacology (togehter with R. Busse, W. Linz and G. Wiemer)


Recent Publications

*

Respiration-Entrained Brain Rhythms Are Global but Often Overlooked. Trends Neurosci. 2018 Feb 8. pii: S0166-2236(18)30031-6. doi: 10.1016/j.tins.2018.01.007. [Epub ahead of print] Review.

*

Modulation of glutathione peroxidase activity by age-dependent carbonylation in glomeruli of diabetic mice. J Diabetes Complications. 2018 Feb;32(2):130-138. doi: 10.1016/j.jdiacomp.2017.11.007. Epub 2017 Nov 22.

*

Bringing European physiologists together. Acta Physiol (Oxf). 2018 Jan 29. doi: 10.1111/apha.13043. [Epub ahead of print]

*

Astrocytic glutamine synthetase is expressed in the neuronal somatic layers and down-regulated proportionally to neuronal loss in the human epileptic hippocampus. Glia. 2018 Jan 19. doi: 10.1002/glia.23292. [Epub ahead of print]

*

Role of protein carbonylation in diabetes. J Inherit Metab Dis. 2018 Jan;41(1):29-38. doi: 10.1007/s10545-017-0104-9. Epub 2017 Nov 6.

*

Sensitive mass spectrometric assay for determination of 15-deoxy-Δ12,14-prostaglandin J2 and its application in human plasma samples of patients with diabetes. Anal Bioanal Chem. 2018 Jan;410(2):521-528. doi: 10.1007/s00216-017-0748-1. Epub 2017 Nov 16.

*

Magnolol inhibits venous remodeling in mice. Sci Rep. 2017 Dec 19;7(1):17820. doi: 10.1038/s41598-017-17910-0.

*

Hypertension-evoked RhoA activity in vascular smooth muscle cells requires RGS5. FASEB J. 2017 Dec 5. pii: fj.201700384RR. doi: 10.1096/fj.201700384RR. [Epub ahead of print]

*

AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome. Mol Ther Nucleic Acids. 2017 Dec 15;9:69-79. doi: 10.1016/j.omtn.2017.08.014. Epub 2017 Sep 20.

*

Allosteric inhibition of carnosinase (CN1) by inducing a conformational shift. J Enzyme Inhib Med Chem. 2017 Dec;32(1):1102-1110. doi: 10.1080/14756366.2017.1355793.

*

Transcription factor decoy technology: a therapeutic update. Biochem Pharmacol. 2017 Nov 15;144:29-34. doi: 10.1016/j.bcp.2017.06.122. Epub 2017 Jun 19. Review.


Institute of
Physiology and Pathophysiology

Heidelberg University

Im Neuenheimer Feld 326

69120 Heidelberg

Germany

Phone:+49 6221 54-4035
Fax:+49 6221 54-4038
E-mail:sekretariat.hecker@
physiologie.uni-heidelberg.de